Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Obesity Surgery
Erschienen in: Obesity Surgery 4/2017

07.10.2016 | Original Contributions

LSG vs OAGB—1 Year Follow-up Data—a Randomized Control Trial

verfasst von: Shivakumar Seetharamaiah, Om Tantia, Ghanshyam Goyal, Tamonas Chaudhuri, Shashi Khanna, Jagat Pal Singh, Anmol Ahuja

Erschienen in: Obesity Surgery | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Laparoscopic sleeve gastrectomy (LSG) is one of the most popular bariatric procedure. One anastomosis gastric bypass (OAGB) is rapidly emerging as a safe and effective metabolic procedure. This study aims at comparing the 1-year follow-up results of OAGB and LSG in terms of excess weight loss, complications, resolution of comorbidities, and quality of life.

Methods

A prospective randomized study of results between 100 LSG and 101 OAGB patients was done from 2012 to 2015. The results were compared regarding operative outcomes, percentage of excess weight loss, complications, resolution of comorbidities, and quality of life (BAROS score).

Results

The mean BMI for the OAGB and LSG group was 44.31 and 43.75 kg/m2, respectively. Percentage of excess weight loss (%EWL) for OAGB vs LSG was 66.87 ± 10.87 vs 63.97 ± 13.24 at 1 year (p > 0.05), respectively. Diabetes remission was 83.63 % in OAGB patients and 76.58 % in LSG patients. Remission of hypertension is 64.15 % in OAGB patients and 66.07 % in LSG patients. Bariatric Analysis Reporting and Outcome System (BAROS) was 3.71 in LSG and 3.96 in OAGB.

Conclusions

In our study, there was no significant difference between LSG and OAGB in outcome at 1 year follow-up in % excess weight loss, remission of HTN, and quality of life. OAGB has marginally better outcome in T2 DM remission. However, a longer follow-up is required to establish a correct comparative result.
Literatur
1.
2.
Lee WJ, Ser KH, Lee YC, et al. Laparoscopic roux-en-Y vs. minigastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.CrossRefPubMed
3.
Noun R, Skaff J, Riachi E, et al. One thousand consecutive minigastric bypass: short and long term outcome. Obes Surg. 2012;22:697–703.CrossRefPubMed
4.
Musella M, Sousa A, Greco F, et al. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multi-center review. Surg Endosc. 2014;28:156–63.CrossRefPubMed
5.
Kular KS, Manchanda N, Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses—first study from Indian subcontinent. Obes Surg. 2014;24:1430–5.CrossRefPubMed
6.
Baltasar A, Serra C, Perez N, et al. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg. 2005;15(8):1124–8.CrossRefPubMed
7.
Eid GM, Brethauer S, Mattar SG, et al. Laparoscopic sleeve gastrectomy for super obese patients: forty-eight percent excess weight loss after 6 to 8 years with 93 % follow-up. Ann Surg. 2012;256(2):262–5.CrossRefPubMed
8.
Sanchez-Santos R, Masdevall C, Baltasar A, et al. Short- and midterm outcomes of sleeve gastrectomy for morbid obesity: the experience of the Spanish National Registry. Obes Surg. 2009;19(9):1203–10.CrossRefPubMed
9.
Rutledge R. The mini-gastric bypass: experience with the 1,274 cases. Obes Surg. 2001;11:276–80.CrossRefPubMed
10.
Mahawar KK, Jennings N, Rown J, et al. “mini” gastric bypass: systematic review of a controversial procedure. Obesity Surg. 2013;23(11):1890–8.CrossRef
11.
Wang HH, Wei PL, Lee YC, et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15:648–54.CrossRefPubMed
12.
Noun R, Zeidan S. Laparoscopic mini-gastric bypass: an effective option for the treatment of morbid obesity. J Chir (Paris). 2007;144:301–4.CrossRef
13.
Quan Y, Huang A, Ye M, et al. Efficacy of laparoscopic mini gastric bypass for obesity and type 2 diabetes mellitus: a systematic review and meta-analysis. Gastroenterol Res Pract. 2015:152852.
14.
Kim Z, Hur KY. Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. World J Surg. 2011;35:631–6.CrossRefPubMed
15.
Lee WJ, Wang W, Lee YC, et al. Effects of laparoscopic minigastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and <35 kg/m2. J Gastrointest Surg. 2008;12:945–52.CrossRefPubMed
16.
Horatio E. Oria, Melodie K. Moorehead. Bariatric analysis and reporting outcome system (BAROS. Obes Surg. 1998;8:487–99.CrossRef
17.
Lakdawala M, Bhasker A, Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of Bariatric and Gastrointestinal Metabolic Surgery for Treatment of Obesity and Type II Diabetes Mellitus in the Asian Population Obesity Surgery. 2010;20(7):929–936
18.
Lee W-J, Chong K, Chen J-C, et al. Predictors of diabetes remission after bariatric surgery in Asia. Asian Journal of Surgery. 2012;35:67e73.CrossRef
19.
Li J, Lai D, Wu D. Laparoscopic roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg. 2016;26:429–42.CrossRefPubMed
20.
Boza C, Gamboa C, Salinas J, et al. Laparoscopic roux–en–Y gastric bypass vs laparoscopic sleeve gastrectomy: a case control study and 3 years of follow up. Surg Obes Relat Dis. 2012;8:243–9.CrossRefPubMed
21.
Kular KS, Manchanda N, Rutledge R. Analysis of the five-year outcomes of sleeve gastrectomy and mini gastric bypass: a report from the Indian sub-continent. Obes Surg. 2014;24:1724–8.CrossRefPubMed
22.
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, roux-en-y gastric bypass and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. doi:10.​1007/​s11695-015-1869-2.
23.
Yehoshua RT, Eidelman LA, Stein M, et al. Laparoscopic sleeve gastrectomy—volume and pressure assessment. Obes Surg. 2008;18:1083–8.CrossRefPubMed
24.
25.
Sacks BC, Mattar SG, Qureshi FG, et al. Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(1):11–6.CrossRefPubMed
26.
Gumbs AA, Duffy AJ, Bell RL. Incidence and management of marginal ulceration after laparoscopic roux-Y gastric bypass. Surg Obes Relat Dis. 2006;2(4):460–3.CrossRefPubMed
27.
Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006;2(4):455–9.CrossRefPubMed
28.
Noun R, Skaff J, Riachi E, et al. One thousand consecutive minigastric bypass: short- and long-term outcome. Obes Surg. 2012;22(5):697–703.CrossRefPubMed
29.
Gagner M, Deitel M, Erickson AL, et al. Survey on laparoscopic sleeve Gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg. 2013.
30.
Musella M, Apers J, Rheinwalt K, et al. Efficacy of bariatric surgery in type 2 diabetes mellitus remission: the role of mini gastric bypass/one anastomosis gastric bypass and sleeve gastrectomy at 1 Year of follow-up. A European survey. Obes Surg. 2015. doi:10.​1007/​s11695-015-1865-6.
31.
Lee W-J, Chong K, Lin Y-H, et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of Incretin effect. Obes Surg. 2014;24:1552–62.CrossRefPubMed
32.
Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143–8.CrossRefPubMed
33.
Milone M, Di Minno MND, Leongito M, et al. Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass. World J Gastroenterol. 2013;19(39):6590–7.CrossRefPubMedPubMedCentral
34.
Bruzzi M, Rau C, Voron T, et al. Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surg Obes Relat Dis. 2015;11:321–6.CrossRefPubMed
35.
Navez J, Dardamanis D, Thissen J-P, et al. Laparoscopic roux-en-Y gastric bypass for morbid obesity: comparison of primary versus Revisional bypass by using the BAROS score. Obes Surg. doi:10.​1007/​s11695-014-1473-x.
36.
Wolf AM, Falcone AR, Kortner B, et al. BAROS: an effective system to evaluate the results of patients after bariatric surgery. Obes Surg. 2000;10(5):445–50.CrossRefPubMed
37.
Suter M, Paroz A, Calmes JM, et al. European experience with laparoscopic roux-en-Y gastric bypass in 466 obese patients. Br J Surg. 2006;93(6):726–32.CrossRefPubMed
38.
Gould JC, Garren MJ, Boll V, et al. Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in supersuper obese patients. Surgery. 2006;140(4):524–9.CrossRefPubMed
39.
Myers JA, Clifford JC, Sarker S, et al. Quality of life after laparoscopic adjustable gastric banding using the Baros and Moorehead-Ardelt quality of life questionnaire II. JSLS. 2006;10(4):414–20.PubMedPubMedCentral
Metadaten
Titel
LSG vs OAGB—1 Year Follow-up Data—a Randomized Control Trial
verfasst von
Shivakumar Seetharamaiah
Om Tantia
Ghanshyam Goyal
Tamonas Chaudhuri
Shashi Khanna
Jagat Pal Singh
Anmol Ahuja
Publikationsdatum
07.10.2016
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 4/2017
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-016-2403-x

Weitere Artikel der Ausgabe 4/2017

Obesity Surgery 4/2017 Zur Ausgabe

Original Contributions

Prediction Model for Hemorrhagic Complications after Laparoscopic Sleeve Gastrectomy: Development of SLEEVE BLEED Calculator

Brief Communication

Long-Term Evaluation of Biliary Reflux After Experimental One-Anastomosis Gastric Bypass in Rats

Original Contributions

Initial Approach to Childhood Obesity in Spain. A Multisociety Expert Panel Assessment

Original Contributions

Conversion of Vertical Sleeve Gastrectomy to a Functional Single-Anastomosis Gastric Bypass: Technique and Preliminary Results Using a Non-Adjustable Ring Instead of Stapled Division

New Concept

Revision of Biliopancreatic Diversion for Side Effects or Insufficient Weight Loss: Codification of a New Procedure

Erratum

Erratum to: The Effect of Bariatric Surgery on Mobility, Health-Related Quality of Life, Healthcare Resource Utilization, and Employment Status

Neu im Fachgebiet Chirurgie

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

10.04.2024 | Narbenhernie | Nachrichten

Deutlich weniger Narbenhernien mit der Small-Bites-Technik
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom CME-Kurs
CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur CME-Kurs
CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis CME-Kurs
CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.